HomeCompareVLCJF vs JNJ

VLCJF vs JNJ: Dividend Comparison 2026

VLCJF yields 1388.89% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VLCJF wins by $349092252.52M in total portfolio value
10 years
VLCJF
VLCJF
● Live price
1388.89%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$349092252.55M
Annual income
$305,782,744,769,607.25
Full VLCJF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VLCJF vs JNJ

📍 VLCJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVLCJFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VLCJF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VLCJF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VLCJF
Annual income on $10K today (after 15% tax)
$118,055.56/yr
After 10yr DRIP, annual income (after tax)
$259,915,333,054,166.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, VLCJF beats the other by $259,915,333,050,180.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VLCJF + JNJ for your $10,000?

VLCJF: 50%JNJ: 50%
100% JNJ50/50100% VLCJF
Portfolio after 10yr
$174546126.29M
Annual income
$152,891,372,387,148.30/yr
Blended yield
87.59%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VLCJF
No analyst data
Altman Z
0.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VLCJF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVLCJFJNJ
Forward yield1388.89%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$349092252.55M$30.3K
Annual income after 10y$305,782,744,769,607.25$4,689.40
Total dividends collected$345914143.96M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VLCJF vs JNJ ($10,000, DRIP)

YearVLCJF PortfolioVLCJF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$149,589$138,888.89$10,592$272.30+$139.0KVLCJF
2$2,101,764$1,941,704.17$11,289$357.73+$2.09MVLCJF
3$27,745,587$25,496,698.84$12,123$472.89+$27.73MVLCJF
4$344,252,548$314,564,770.13$13,141$629.86+$344.24MVLCJF
5$4,015,969,955$3,647,619,728.63$14,408$846.81+$4015.96MVLCJF
6$44,065,575,004$39,768,487,152.56$16,021$1,151.60+$44065.56MVLCJF
7$454,966,182,505$407,816,017,250.52$18,122$1,588.22+$454966.16MVLCJF
8$4,421,953,714,186$3,935,139,898,905.55$20,930$2,228.20+$4421953.69MVLCJF
9$40,476,175,496,698$35,744,685,022,519.10$24,792$3,191.91+$40476175.47MVLCJF
10$349,092,252,551,074$305,782,744,769,607.25$30,274$4,689.40+$349092252.52MVLCJF

VLCJF vs JNJ: Complete Analysis 2026

VLCJFStock

Velocity Minerals Ltd., a gold exploration and development company, engages in the acquisition, exploration, and evaluation of mineral resource properties in Bulgaria. It explores for gold and copper deposits. The company holds a 70% interest in the Tintyava property, which includes the Rozino gold project located in the municipalities of Ivaylovgrad and Krumovgrad in southeast Bulgaria; a 70% interest in the Momchil property, which includes the Obichnik gold project; and a 100% interest in the Iglika property covering an area of 105 square kilometers located in southeast Bulgaria. It also holds an option agreement to earn a 70% interest in the Nadezhda Project, which includes the Makedontsi gold project. The company is headquartered in Vancouver, Canada.

Full VLCJF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VLCJF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VLCJF vs SCHDVLCJF vs JEPIVLCJF vs OVLCJF vs KOVLCJF vs MAINVLCJF vs ABBVVLCJF vs MRKVLCJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.